Skip to content

Figuring Out the Genetic Mutations That Lead to Lower Jaw Advancement More Than the Upper Jaw

Investigating Genetic Biomarkers in the Early Detection of Skeletal Class III Malocclusion: An Observational Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07749638
Enrollment
93
Registered
2026-08-06
Start date
2023-10-01
Completion date
2026-07-09
Last updated
2026-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skeletal Class III Malocclusion

Keywords

skeletal class III malocclusion, Genetic mutation, SNPs

Brief summary

Purpose of the Research: To reveal the genetic cause for the occurrence of Class III malocclusion, or what may be described as a reverse bite (underbite). Introduction and Detailed Procedures for the Patient (Work Plan): 1. The volunteer will rinse their mouth with chlorhexidine before taking the swab. 2. A saliva sample will be collected from the patient using a syringe, along with a frontal facial photograph and a lateral cephalometric X-ray. 3. DNA / genetic material will be extracted from the sample. 4. Screening will be conducted for genetic mutations that may be responsible for the occurrence of the underbite. 5. The photographs and X-rays will be analyzed and compared with the swab results. 6. This data will be analyzed to determine whether the detected mutations are the cause of the underbite. 7. The sample will be retained for use in future research studies. Side Effects, Expected Risk Levels, and Management" * Pain: Mild discomfort during swab collection, which does not require any painkillers. * Infection/Inflammation: Mild inflammation at the sample site or a secondary bacterial infection; in this case, antibiotics may be prescribed if necessary. * Risk Level: Low risk, estimated to be less than 5%.

Interventions

None listed

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
10 Years to No maximum

Inclusion criteria

for Control group: * Patients of Egyptian nationality. * ANB from 0° to 4.8°.ANB from 0° to 4.8°. * Wits appraisal no less than -3.0 mm. Inclusion Criteria for Study group: * Patients of Egyptian nationality. * ANB (angle between point A, nasion and point B at nasion) angle (point A-nasion point B) of less than 0 degrees. * Negative Wits appraisal greater than -3.0 mm.

Exclusion criteria

* The presence of any growth disturbances, syndromes, congenital abnormalities, \& endocrine disorders. * Patients subjected to previous orthodontic, orthopedic, or orthognathic treatment. * Poor quality of radiographic records. * Consent form not signed. * Trauma.

Design outcomes

Primary

MeasureTime frameDescription
presence of single nucleotide polymorphismcross-sectional - results are assessed at one point of time (Preintervention)difference in snps between control and study group

Secondary

MeasureTime frameDescription
lateral cephalometric measurementscross-sectional - results are assessed at one point of time (Preintervention)if the snps found have a correlation with different linear and angular measurements
Frontal photos measurementscross-sectional - results are assessed at one point of time (Preintervention)If the snps found have a correlation with different ratios on frontal photos:

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 7, 2026